British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Nicholas A Kennedy; Gareth-Rhys Jones; Christopher A Lamb; Richard Appleby; Ian Arnott; R Mark Beattie; Stuart Bloom; Alenka J Brooks; Rachel Cooney; Robin J Dart; Cathryn Edwards; Aileen Fraser; Daniel R Gaya; Subrata Ghosh; Kay Greveson; Richard Hansen; Ailsa Hart; A Barney Hawthorne; Bu'Hussain Hayee; Jimmy K Limdi; Charles D Murray; Gareth C Parkes; Miles Parkes; Kamal Patel; Richard C Pollok; Nick Powell; Chris S Probert; Tim Raine; Shaji Sebastian; Christian Selinger; Philip J Smith; Catherine Stansfield; Lisa Younge; James O Lindsay; Peter M Irving; Charlie W Lees

doi:10.1136/gutjnl-2020-321244

Retour

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Article de revue

Avec comité de lecture

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, Richard Appleby, Ian Arnott, R Mark Beattie, Stuart Bloom, Alenka J Brooks, Rachel Cooney, Robin J Dart, …

Gut, Vol.69(6), pp.984-990

01/06/2020

DOI: https://doi.org/10.1136/gutjnl-2020-321244

PMID: 32303607

Résumé

The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government’s advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Créateurs - sans rôle: Nicholas A Kennedy - University of Exeter, Exeter, UK
Gareth-Rhys Jones - Western General Hospital, Edinburgh, UK
Christopher A Lamb - Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Richard Appleby - Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
Ian Arnott - Western General Hospital, Edinburgh, UK
R Mark Beattie - Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK
Stuart Bloom - University College London Hospitals NHS Foundation Trust, London, UK
Alenka J Brooks - Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Rachel Cooney - University of Birmingham, Birmingham, UK
Robin J Dart - The Royal Free Hospital, London, UK
Cathryn Edwards - Torbay and South Devon NHS Foundation Trust, Torquay, UK
Aileen Fraser - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Daniel R Gaya - University of Glasgow, Glasgow, UK
Subrata Ghosh - University of Birmingham, Birmingham, UK
Kay Greveson - The Royal Free Hospital, London, UK
Richard Hansen - Royal Hospital for Children, Glasgow, UK
Ailsa Hart - Imperial College London, London, UK
A Barney Hawthorne - University Hospital of Wales, Cardiff, UK
Bu'Hussain Hayee - King’s College Hospital NHS Foundation Trust, London, UK
Jimmy K Limdi - University of Manchester, Manchester, UK
Charles D Murray - The Royal Free Hospital, London, UK
Gareth C Parkes - The Royal London Hospital, Barts Health NHS Trust, London, UK
Miles Parkes - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Kamal Patel - St George’s University Hospitals NHS Foundation Trust, London, UK
Richard C Pollok - St George’s, University of London, London, UK
Nick Powell - Imperial College Healthcare NHS Trust, London, UK
Chris S Probert - University of Liverpool, Liverpool, UK
Tim Raine - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Shaji Sebastian - Hull University Teaching Hospitals NHS Trust, Hull, UK
Christian Selinger - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Philip J Smith - Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK
Catherine Stansfield - Salford Royal NHS Foundation Trust, Salford, UK
Lisa Younge - Crohn's and Colitis UK, St Albans, Hertfordshire, UK
James O Lindsay - The Royal London Hospital, Barts Health NHS Trust, London, UK
Peter M Irving - Guy's and St Thomas' NHS Foundation Trust, London, UK
Charlie W Lees - Western General Hospital, Edinburgh, UK
Détails de publication: Gut, Vol.69(6), pp.984-990
Nombre de pages: 7
Identifiants: 99158956309311
Unité académique: Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle - MIVEGEC
Langue: English
Type de ressource: Journal article